Vinva Investment Management Ltd Buys New Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Vinva Investment Management Ltd bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 3,218 shares of the biotechnology company’s stock, valued at approximately $1,272,000.

Other hedge funds have also modified their holdings of the company. Quent Capital LLC raised its holdings in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Blue Trust Inc. increased its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the last quarter. Brooklyn Investment Group purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $41,000. Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the last quarter. Finally, Friedenthal Financial purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $51,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AXON has been the topic of several analyst reports. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. JMP Securities lifted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Robert W. Baird lifted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 75,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the sale, the chief executive officer now owns 2,970,366 shares of the company’s stock, valued at $1,059,024,589.98. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Julie A. Cullivan sold 900 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the sale, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. The trade was a 19.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 210,256 shares of company stock valued at $87,783,120 over the last quarter. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

AXON opened at $646.96 on Friday. The business’s 50 day moving average is $483.18 and its 200-day moving average is $376.61. The stock has a market cap of $49.33 billion, a PE ratio of 167.17, a price-to-earnings-growth ratio of 13.97 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $652.22.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.